As part of our ongoing ‘pandemic perspectives‘ series, Gavin Giovannoni (Barts and the London School of Medicine and Dentistry, UK) provides his insights into how the COVID-19 pandemic has affected neurological practice, particularly in relation to multiple sclerosis. This includes the shift to telemedicine consultation for patients, managing treatments, vaccine implications and the impact that the pandemic is having on research agendas. Watch the full video above to find out more.
More content on COVID-19:
The opinions expressed in this video are those of the interviewee and do not necessarily reflect the views of Neuro Central or Future Science Group.